— Know what they know.
Not Investment Advice
Also trades as: LIXTW (NASDAQ) · $vol 0M

LIXT NASDAQ

Lixte Biotechnology Holdings, Inc.
1W: +8.4% 1M: +2.4% 3M: +134.8% YTD: +87.8% 1Y: +511.0% 3Y: +20.0% 5Y: -75.5%
$7.21
Last traded 2026-07-02 — delisted
NASDAQ · Healthcare · Biotechnology · $89.1M mcap · 11M float · 2.15% daily turnover · Short 51% of daily vol

Balance Sheet Trends

Total Assets
$1M -73.4% ▼
5Y CAGR: -15.6%
Total Liabilities
$318K +1.4% ▲
5Y CAGR: +6.0%
Shareholders Equity
$827K -79.3% ▼
5Y CAGR: -19.4%
Cash & Investments
$1M -75.3% ▼
5Y CAGR: -16.8%
Total Debt
$0 +0.0% ▲
Net Debt
-$1M +75.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$5M$5M$5M$4M$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$5M$5M$5M$4M$1M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$15K$150K$0$0-$107K
Total Current Assets$5M$5M$6M$4M$1M
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$77K$0$0$0$107K
Total Non-Current Assets$77K$0$0$0$107K
Total Assets$5M$5M$6M$4M$1M
— Liabilities —
Accounts Payable$190K$193K$184K$121K$83K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$16K$0$165K$157K$235K
Other Current Liabilities$0$77K$0$0$0
Total Current Liabilities$217K$303K$396K$314K$318K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0-$0$0$0$0
Total Non-Current Liabilities$0-$0$0$0$0
Total Liabilities$217K$303K$396K$314K$318K
— Equity —
Common Stock$1K$1K$166$225$225
Retained Earnings-$30M-$37M-$43M-$48M-$52M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$5M$5M$5M$4M$827K
Total Liabilities & Equity$5M$5M$6M$4M$1M
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$5M-$5M-$5M-$4M-$1M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms